Molecular and clinical features of KATP -channel neonatal diabetes mellitus in Japan.
about
Neonatal Diabetes and the KATP Channel: From Mutation to Therapy.Sulfonylurea treatment in an infant with transient neonatal diabetes mellitus caused by an adenosine triphosphate binding cassette subfamily C member 8 gene mutation.KATP Channel Mutations and Neonatal Diabetes.Sulfonylurea for the treatment of neonatal diabetes owing to KATP-channel mutations: a systematic review and meta-analysis.Hypoglycemia in sulfonylurea-treated KCNJ11-neonatal diabetes: Mild-moderate symptomatic episodes occur infrequently but none involving unconsciousness or seizures.The role of KATP channels in cerebral ischemic stroke and diabetes.
P2860
Molecular and clinical features of KATP -channel neonatal diabetes mellitus in Japan.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Molecular and clinical features of KATP -channel neonatal diabetes mellitus in Japan.
@en
Molecular and clinical features of KATP -channel neonatal diabetes mellitus in Japan.
@nl
type
label
Molecular and clinical features of KATP -channel neonatal diabetes mellitus in Japan.
@en
Molecular and clinical features of KATP -channel neonatal diabetes mellitus in Japan.
@nl
prefLabel
Molecular and clinical features of KATP -channel neonatal diabetes mellitus in Japan.
@en
Molecular and clinical features of KATP -channel neonatal diabetes mellitus in Japan.
@nl
P2093
P2860
P356
P1433
P1476
Molecular and clinical features of KATP -channel neonatal diabetes mellitus in Japan.
@en
P2093
Haruo Mizuno
Hidenori Sugawara
Hirotake Sawada
Kenichi Satomura
Kenji Shirai
Koichi Maruyama
Masakazu Hirose
Shigetaka Sugihara
Sumito Dateki
Tatsuhiko Urakami
P2860
P356
10.1111/PEDI.12447
P577
2016-09-29T00:00:00Z